| Domain | Rank | Visitors | Earning per month | Valuation |
| trellahealth.com | 1238780 | 316 | 59$ | 1770$ |
| prognoshealth.com | 1200587 | 134 | 24$ | 720$ |
| truveta.com | 1950803 | 424 | 79$ | 2370$ |
| pepgra.com | 3232911 | 128 | 36$ | 1080$ |
| retinaleyecare.com | None | 0 | 48$ | 1440$ |
| carejourney.com | 3128760 | 274 | 54$ | 1620$ |
| trella.app | 721357 | 198 | 46$ | 1380$ |
| excelhealth.ca | 4819527 | 56 | 10$ | 300$ |
| Moz Backlinks Count | 128 |
| Moz Page Rank | 2 |
| Domain Authority (DA) | 27.0 |
| Page Authority (PA) | 21.0 |
| Country | Rank | Pct |
|---|
| Country Name | Unknown |
| Daily unique visits | 3,584 |
| Daily Page Views | 3,584 |
| Income Per Day | 333 USD |
| Veranahealth.com valuation | 9990 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | The Possibilities of Unlocking Real-World Data to Help Transform Patient Lives |
| No | Text |
| 1 | Society Partnerships |
| 2 | Research Redefined |
| 3 | San Francisco | New York | Knoxville |
| No | Text |
| 1 | Rabia Gurses Ozden, MD |
| 2 | 2023 IRIS Registry Report Demonstrates the Transformative Power of Curated Real-World Data on Real-World Evidence Generation |
| 3 | Real-World Clinical and Anatomical Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: The FARETINA-DME Study |
| 4 | IRIS® Registry Analysis of Anti-VEGF Treatment in Patients With Coexisting Neovascular Age-Related Macular Degeneration and Geographic Atrophy |
| 5 | Qdata® Thyroid Eye Disease Provides Real-World Evidence Analytics to Help Improve Understanding of Rare Condition |
| 6 | A Natural Language Processing Approach to Identify Patients with Uveitic Macular Edema in the IRIS®️ Registry |
| 7 | Automated Segmentation of Geographic Atrophy Using Machine Learning on Real-World Fundus Autofluorescence Ophthalmic Images in the IRIS®️ Registry |
| Social | Count |
| Facebook Likes | 6 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |